Elsevier

Biochemical Pharmacology

Volume 78, Issue 7, 1 October 2009, Pages 703-711
Biochemical Pharmacology

Review
Structural and functional diversity of native brain neuronal nicotinic receptors

https://doi.org/10.1016/j.bcp.2009.05.024Get rights and content

Abstract

Neuronal nicotinic acetylcholine receptors (nAChRs) are a family of ligand-gated ion channels present in the central and peripheral nervous systems, that are permeable to mono- and divalent cations. They share a common basic structure but their pharmacological and functional properties arise from the wide range of different subunit combinations making up distinctive subtypes.

nAChRs are involved in many physiological functions in the central and peripheral nervous systems, and are the targets of the widely used drug of abuse nicotine. In addition to tobacco dependence, changes in their number and/or function are associated with neuropsychiatric disorders, ranging from epilepsy to dementia.

Although some of the neural circuits involved in the acute and chronic effects of nicotine have been identified, much less is known about which native nAChR subtypes are involved in specific physiological functions and pathophysiological conditions.

We briefly review some recent findings concerning the structure and function of native nAChRs, focusing on the subtypes identified in the mesostriatal and habenulo-interpeduncular pathways, two systems involved in nicotine reinforcement and withdrawal. We also discuss recent findings concerning the effect of chronic nicotine on the expression of native subtypes.

Introduction

Nicotine is a major component of tobacco smoke whose behavioural effects are due to its interactions with a family of acetylcholine (ACh)-gated channels (nicotinic ACh receptors, nAChRs) present in the central and peripheral nervous systems [1], [2], [3], [4], [5]. These share a common basic structure but have specific pharmacological and functional properties that are due to the very different subunit combinations that make distinctive subtypes. nAChRs are not only permeable to monovalent Na+ and K+ ions, but also to Ca2+ ions, and their ability to alter intracellular [Ca2+] [6] by activating different downstream intracellular pathways plays a pivotal role in neuron signalling (reviewed in [7]).

Brain nAChRs have a very widespread and non-uniform distribution. The majority have a presynaptic and/or preterminal localisation where they modulate the release of almost all neurotransmitters, but some also have a somatodendritic post-synaptic localisation [3], [4]. The activation of nAChRs can have opposite modulatory effects in the same circuit depending on where they are expressed (for instance on excitatory or inhibitory neurons) [3], [8]. nAChRs are involved in a wide range of physiological functions in the central and peripheral nervous system, and changes in their number and/or function are associated with a number of pathophysiological conditions.

The recent development of genetically engineered mice with the targeted deletion of specific subunits (knock-out mice, Ko) or mutations in critical receptor domains (knock-in mice, Kin), as well as Ko mice made to re-express nAChR subunits in selected brain regions by means of lentiviral vectors, has led to the in vivo identification of complex subtypes and allowed the study of individual subtypes in specific cells and complex neurobiological systems (reviewed in [1], [9], [10], [11], [12]).

As a number of comprehensive reviews have described the structure and function of nAChRs [3], [4], [5], [13], [14], the aim of this article is to provide a short overview of some aspects that have been the object of recent studies: the composition and function of native nAChR subtypes, particularly those present in the mesostriatal and habenulo-interpeduncular pathways, and how they are modulated by chronic exposure to nicotine.

Section snippets

Structure of the nAChR

nAChRs form a heterogeneous family of subtypes consisting of five subunits arranged around a central pore whose variety is mainly due to the diversity of the possible combinations of the known nine α (α2–α10) and three β (β2–β4) subunits [15]. Unlike the β subunits, all nine α subunits have adjacent cysteines, analogous to cysteines 192–193 of the α subunit of muscle-type nAChRs [16]. The subunits have been cloned from neuron-like cells or cDNA libraries obtained from vertebrate brain, but it

Role of non-ligand-binding (accessory) subunits in pentameric receptors

In heteromeric αBgtx-insensitive receptors, the accessory subunits are those that do not directly participate in forming the binding site. Heterologous expression studies have shown that the α5 and β3 subunits only form functional channels when they are co-expressed with a principal and a complementary subunit [34], [35], thus indicating that they can only function as accessory subunits, whereas the α3 or α4 and β2 or β4 subunits can form ligand binding sites or assemble in the accessory

Subunit stoichiometry

As nAChRs are pentameric, they can show considerable molecular diversity. In addition to the differences in subunit composition, some receptor subtypes may have the same subunit composition but different subunit stoichiometries.

Two different methodological approaches have shown that heterologously expressed α4β2 subtypes have an (α4)2(β2)3 stoichiometry that is highly sensitive to activation by ACh [44], [45]. Subsequently it has been found that the α4β2 subtype has biphasic ACh

nAChR subtype assembly

Expression studies using heterologous systems have shown that nAChR assembly is a tightly regulated and ordered process, which requires appropriate subunit–subunit interactions and perhaps other proteins (chaperones) that can assist receptor assembly [52], [53]. Vertebrate nAChR subunits may co-assemble in many possible combinations, and many more subtypes have been heterologously expressed than those identified in vivo. It seems that native nAChRs are assembled into functional pentamers with a

Native nAChR subtypes

Important contributions to the identification of native nAChRs in the brains of rats and wild-type, Ko and Kin mice have been made using biochemical, immunoprecipitation and immunopurification techniques. It is now well established that the most abundant nAChR subtypes in the nervous system are homomeric α7 receptors and heteromeric receptors containing only one type of α and one type of β subunit [2], [4]. The α4β2* receptors account for 90% of the high affinity neuronal nAChRs in mammalian

Regulation of native subtypes by chronic nicotine exposure

Chronic nicotine exposure gives rise to neural adaptations that change whole cell physiology and behaviour, mainly due to its interaction with nAChRs.

The effects of nicotine may be due to nAChR activation or desensitisation because, also in the latter case, nicotine can alter neuronal function by interrupting the transmission of endogenous ACh [30], [97]. As nAChR subtypes are not equally responsive to nicotine activation and desensitisation, this can influence their functional and behavioural

Conclusions

The fine molecular structure of nAChRs has been better clarified over recent years mainly as a result of very different methodological approaches.

It has been shown that there is a substantial number of native subtypes, although native nAChRs are assembled into functional pentamers made up of a relatively restricted number of subunit combinations. Moreover, the in vivo characterisation of new and unsuspected subtypes (heteromeric α7β2) has increased the complexity of studying native subtypes.

Acknowledgements

The paper was supported by Italian PRIN grant 20072BTSR2 to FC and MZ, and EC Neurocypres grant no. 202088 to CG and MZ, and grants from Fondazione Cariplo (2006/0779/109251) and Compagnia San Paolo (2005-1964) to CG.

Our special thanks go to Dr. Annalisa Gaimarri for drawing the figures.

References (125)

  • P.H. Celie et al.

    Crystal structure of acetylcholine-binding protein from Bulinus truncatus reveals the conserved structural scaffold and sites of variation in nicotinic acetylcholine receptors

    J Biol Chem

    (2005)
  • P.H. Celie et al.

    Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures

    Neuron

    (2004)
  • N. Unwin

    Refined structure of the nicotinic acetylcholine receptor at 4A resolution

    J Mol Biol

    (2005)
  • R. Giniatullin et al.

    Desensitization of nicotinic ACh receptors: shaping cholinergic signaling

    Trends Neurosci

    (2005)
  • M.R. Picciotto et al.

    It is not “either/or”: activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood

    Prog Neurobiol

    (2008)
  • C. Gotti et al.

    Brain nicotinic acetylcholine receptors: native subtypes and their relevance

    Trends Pharmacol Sci

    (2006)
  • P.J. Groot-Kormelink et al.

    A reporter mutation approach shows incorporation of the “orphan” subunit beta3 into a functional nicotinic receptor

    J Biol Chem

    (1998)
  • E. Palma et al.

    Nicotinic acetylcholine receptors assembled from the alpha7 and beta3 subunits

    J Biol Chem

    (1999)
  • R. Anand et al.

    Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure

    J Biol Chem

    (1991)
  • W. Sweileh et al.

    Multistep expression and assembly of neuronal nicotinic receptors is both host-cell- and receptor-subtype-dependent

    Brain Res Mol Brain Res

    (2000)
  • R.M. Drenan et al.

    In vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha 6 nicotinic acetylcholine receptors

    Neuron

    (2008)
  • S.D. Glick et al.

    18-Methoxycoronaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in rats

    Eur J Pharmacol

    (2006)
  • W.G. Conroy et al.

    Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions

    J Biol Chem

    (1995)
  • L. Lecourtier et al.

    A conductor hidden in the orchestra? Role of the habenular complex in monoamine transmission and cognition

    Neurosci Biobehav Rev

    (2007)
  • T. Li et al.

    Noxious somatic stimulation-induced expression of Fos-like immunoreactivity in catecholaminergic neurons with habenular nucleus projection in the medullary visceral zone of rat

    Brain Res

    (1998)
  • B. Buisson et al.

    Nicotine addiction: the possible role of functional upregulation

    Trends Pharmacol Sci

    (2002)
  • R. Nashmi et al.

    Cell autonomy, receptor autonomy, and thermodynamics in nicotine receptor up-regulation

    Biochem Pharmacol

    (2007)
  • J.A. Dani et al.

    Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system

    Annu Rev Pharmacol Toxicol

    (2007)
  • E.X. Albuquerque et al.

    Mammalian nicotinic acetylcholine receptors: from structure to function

    Physiol Rev

    (2009)
  • A.A. Jensen et al.

    Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations

    J Med Chem

    (2005)
  • N. Champtiaux et al.

    Knock-out and knock-in mice to investigate the role of nicotinic receptors in the central nervous system

    Curr Drug Targets CNS Neurol Disord

    (2002)
  • J. Drago et al.

    Neuronal nicotinic receptors: insights gained from gene knockout and knockin mutant mice

    Cell Mol Life Sci

    (2003)
  • U. Maskos

    Emerging concepts: novel integration of in vivo approaches to localize the function of nicotinic receptors

    J Neurochem

    (2007)
  • C.D. Fowler et al.

    Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice

    Behav Pharmacol

    (2008)
  • S.M. Sine et al.

    Recent advances in Cys-loop receptor structure and function

    Nature

    (2006)
  • I. Wessler et al.

    Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans

    Br J Pharmacol

    (2008)
  • H.M. Schuller

    Is cancer triggered by altered signalling of nicotinic acetylcholine receptors?

    Nat Rev Cancer

    (2009)
  • K. Kawashima et al.

    Basic and clinical aspects of non-neuronal acetylcholine: overview of non-neuronal cholinergic systems and their biological significance

    J Pharmacol Sci

    (2008)
  • S.B. Hansen et al.

    Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations

    EMBO J

    (2005)
  • R.J. Hilf et al.

    X-ray structure of a prokaryotic pentameric ligand-gated ion channel

    Nature

    (2008)
  • R.J. Hilf et al.

    Structure of a potentially open state of a proton-activated pentameric ligand-gated ion channel

    Nature

    (2009)
  • N. Bocquet et al.

    X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation

    Nature

    (2009)
  • A.B. Elgoyhen et al.

    alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells

    Proc Natl Acad Sci USA

    (2001)
  • F. Sgard et al.

    A novel human nicotinic receptor subunit, alpha10, that confers functionality to the alpha9-subunit

    Mol Pharmacol

    (2002)
  • J. Ramirez-Latorre et al.

    Functional contributions of alpha5 subunit to neuronal acetylcholine receptor channels

    Nature

    (1996)
  • P.J. Corringer et al.

    Nicotinic receptors at the amino acid level

    Annu Rev Pharmacol Toxicol

    (2000)
  • A. Kuryatov et al.

    Roles of accessory subunits in alpha4beta2(*) nicotinic receptors

    Mol Pharmacol

    (2008)
  • M. Moroni et al.

    alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine

    Mol Pharmacol

    (2006)
  • L. Tapia et al.

    Ca2+ permeability of the (alpha4)3(beta2)2 stoichiometry greatly exceeds that of (alpha4)2(beta2)3 human acetylcholine receptors

    Mol Pharmacol

    (2007)
  • M. Moroni et al.

    Non-agonist-binding subunit interfaces confer distinct functional signatures to the alternate stoichiometries of the alpha4beta2 nicotinic receptor: an alpha4-alpha4 interface is required for Zn2+ potentiation

    J Neurosci

    (2008)
  • Cited by (393)

    View all citing articles on Scopus
    View full text